☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Regulatory Approval
World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan
August 31, 2020
Roche's Enspryng (satralizumab) Receives MHLW's Approval for Neuromyelitis Optica Spectrum Disorder in Japan
June 29, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.